-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Lipocine at Buy, Announces Price Target of $8

Benzinga·05/29/2025 14:46:45
Listen to the news
HC Wainwright & Co. analyst Yi Chen assumes Lipocine (NASDAQ:LPCN) with a Buy rating and announces Price Target of $8.